Haoxi Health Technology shareholders approve share capital reduction at EGM

• Haoxi Health Technology held an extraordinary general meeting on July 6, 2026.
• Shareholders passed a special resolution to authorize a share capital reduction and reorganization, cutting par value to USD 0.0000001 per share.
• The vote also authorized transferring the resulting credit to a distributable reserve account; the filing does not confirm the reduction has been completed.
• Shareholders adopted a ninth amended and restated memorandum and articles of association to reflect the proposed share capital reduction.
• An ordinary resolution to allow adjournment for additional proxy solicitation, if needed, was also carried.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Haoxi Health Technology Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-075499), on July 06, 2026, and is solely responsible for the information contained therein.